Consider this, the Airocide® bioconversion system is clinically proven to eliminate 99.999 percent of all airborne microorganisms. Proven in clinical studies. Proven in real world working operating theatres. Even eliminating harmful VOCs—protecting the lives of patients and those who care for them.
Coughs and sneezes, viruses and bacteria of all kinds surround your patients and your staff. If either one is sick, they’re likely to infect the other. Moreover, the bacteria and viruses they are carrying linger long after people have left the building.
In a single practitioner’s office as many as six patients an hour impact the air. In a joint practice, that number jumps considerably. Add nurse practitioners and larger facilities and it grows even larger. Physicians, nurses and staff are all affected, as well as every one of your patients seeking to get better, not worse.
The good news … there is simple treatment that dramatically drops the colony forming unit (CFU) count of airborne pathogens. The Airocide bioconversion system.
Everyone at Airocide are delighted with the ground-breaking report received from the Institut Pastuer on a study in a controlled classroom environment, that SARS CoV-2 was detected on entering the air intake of an Airocide HD 25000.
The report conclusively determines that the virus WAS NOT present once it had passed through the reaction chamber. This is obviously some much needed news on the continued fight with Covid 19.
There has been much academic research conducted regarding Airocide effectiveness. Some of that research is provided here.
Middle East Respiratory Syndrome (MERS) is caused by a coronavirus called the Middle East Respiratory Syndrome Coronavirus. Appropriate nomenclature in your author’s humble opinion. Once the virus successfully infects a human host, the symptoms are severe fever, cough, and shortness of breath.
In some cases there were gastrointestinal symptoms reported. Unfortunately, four out of ten people who develop symptoms perish. The first reported case of MERS-CoV occurred in Saudi Arabia in 2012, and it has arisen spontaneously in several other countries in the region since that time. But, to further the point I made previously, the most deadly outbreak occurred in South Korea in 2015. So, it is by no means geographically confined.
MERS-CoV is spread by an infected person’s respiratory secretions, and primarily coughing. Most reported new cases were from those living with an infected person. While understanding the full mechanism of MERS-CoV transmission is still a work in progress, researchers have determined that the virus can only infect about 20% of the epithelial cells in lungs. This means that there must be a large viral lode for successful transmission. And, this is where Airocide can have a meaningful impact in arresting the spread of MERS-CoV. The Airocide NASA PCO technology has been proven to eliminate virions (inert virus particles) in the ambient air per the Bacteriophage reduction study conducted in Wisconsin.
The average cough or sneeze has a radius of two to five meters from the subject, and the virus has a pernicious survival time. By reducing the viral lode within a space, the Airocide can have a dramatic impact on transmission rates of MERS-CoV by decreasing the number of virions available to infect the limited number of susceptible respiratory cells.
Prevention of MERS-CoV is equally applicable to both our industrial and consumer products. There is a rising concern about disease transmission in public spaces and health care facilities. There is also serious concern about the spread of illness within the home, as this as the most common infection point for MERS-CoV (as well as other conditions). The Airocide NASA PCO technology is unique in servicing this particular need. Common HEPA filters used in HVAC systems or air sanitizing devices are simply too permeable for viruses.
David A.Ghelerter
Chief Science and Technology Officer, Airocide
Tests were conducted in August of 2002 with analyses conducted in August and September. The effluent from the Airocide device was sampled and analyzed to determine gas species and concentrations. Ozone was found to be below detectable levels and the volitile organic compounds were found to be very low in the ppb (parts ber billion range).
The authors provide a research study examining the airborne microbial killing efficiency of the Airocide Air Quality-Improvement System (Airocide bioconversion system), a unique photo-catalytic reactor. The study examines baseline bacterial and fungal cultures, commonly known as pathogens, collected at specific clinical test areas.
Spores that pass through the box aren’t filtered, they’re fried,” says John Hayman, Chief Science Officer for Akida Holdings, the manufacture and marketer of Airocide. “That’s appealing,” he notes, “for people who don’t want to change an Anthrax-laden air filter.”
A total of 60,865 spores entered the reactor and of this inoculum, a total of 5 CFUs exited the devide and were collected on the surface of the seven sets of blood agar plates over the 70-min sampling period. After each 10-min sampling period culture plates were covered and labeled. A total of 14 culture plates were incubated overnight at 35 degrees Celsius. The CFUs of B. thuringiensis were counted and recorded for each culture plate.
Airocide was tested in a 1m³ dynamic environmental chamber following the guidelines of ASTM D 5116 (1). Ozone monitoring was conducted with a Thermo Environmental Model 49 Ozone Analyzer. This analyzer operates based on the strong UV absorbance of ozone at 254 nm. The chamber was continuously monitored for ozone over a five hour period. Ozone, if any, was below the minimum quantifiable level of 10 μg/m³ (5 ppb (parts per billion).
Tests were conducted in August of 2002 with analyses conducted in August and September. The effluent from the Airocide device was sampled and analyzed to determine gas species and concentrations. Ozone was found to be below detectable levels and the volitile organic compounds were found to be very low in the ppb (parts ber billion range).
The authors provide a research study examining the airborne microbial killing efficiency of the Airocide Air Quality-Improvement System (Airocide bioconversion system), a unique photo-catalytic reactor. The study examines baseline bacterial and fungal cultures, commonly known as pathogens, collected at specific clinical test areas.
Whole cells deposited on a titanium dioxide-coated surface have been oxidized in air to carbon dioxide via photocatalysis. This paper provides the first evidence that the organic matter in whole cells can be completely oxidized.
A study was performed examining the airborne microbial killing efficiency of the Airocide® bioconversion system. The study was conducted in coordination with the medical microbiology & immunology and biomedical engineering departments of a major state university and examined baseline bacterial and fungal cultures, commonly known as pathogens, collected at specific clinical test areas. Samples of unique clinical interest such as methicillin resistant Staphylococcus aureus (MRSA) were studied in depth. Results of the test showed bacteria reductions of 69% in an Ear, Nose & Throat (ENT) Day Surgery procedure room, 25% in a Surgical Operating Room (OR) and 95% in a Surgical Instrument Sterile Preparation Room. MRSA was present in the OR and reduced by 100% after use of the Airocide system.
A clinical test of the Airocide® bioconversion system was conducted in a pediatrician’s office complex. The primary objective of the test was to determine the effect on airborne bacteria of turning off an Airocide system that had been operating 24/7 for 6 months inside a pediatric facility. The secondary objective was to measure the difference in performance of the Airocide system in a pediatric “sick” waiting room compared to a pediatric “well” waiting room. In 24 hours after turning off the Airocide system the airborne bacteria in the facility increased by an average of 181%. One week later the average level of airborne bacteria was 211% higher than when the Airocide system was operating.
ABSTRACT. An onsite study determined changes in the colony forming unit (CFU) count of airborne bacteria and fungi/mold in two waiting rooms of a primary care pediatric office as a result of using an Airocide bioconversion system. The data supports the hypothesis that levels of airborne bacteria and mold/fungi begin to increase when the Airocide system is turned off after continuous operation for a given period of time.
© 2021 UVC Clean Air Systems. All rights reserved